Given the direct correlation between S100A8/A9 levels, MDSC levels, and tumor progression, studies in human prostate cancer [40], colon cancer [55], and gastric cancer [41] have concluded that S100A8 and/or A9 are early biomarkers and are diagnostic for cancer progression. This evidence concerns the gene IGKV1D-22 and prostate cancer.